Comparative Expression of CD45RA by CD48+(Normal) and CD48− (GPI-Deficient) Components of CD4+ and CD8+ T-Cell Subpopulations in Patients With PNH
Patient ID . | CD4+Lymphocytes3-150 . | CD8+ Lymphocytes3-150 . | ||||
---|---|---|---|---|---|---|
Size of PNH Clone % . | CD48+CD45RA+ % . | CD48−CD45RA+ % . | Size of PNH Clone % . | CD48+CD45RA+ % . | CD48−CD45RA+ % . | |
PNH007 | 24.3 | 37 | 83 | 35.8 | 89 | 99 |
PNH008 | 23.5 | 21 | 71 | 22.2 | 47 | 97 |
PNH012 | 21.3 | 40 | 89 | 32.3 | 95 | 99 |
PNH019 | 10.7 | 18 | 67 | 12.6 | 67 | 85 |
PNH020 | 16.2 | 56 | 83 | 18.2 | 44 | 98 |
PNH022 | 7.9 | 28 | 74 | 11.1 | 58 | 90 |
PNH0303-151 | 14.0 | 32 | 46 | 4.3 | 63 | 59 |
PNH033 | 21.7 | 37 | 77 | 20.7 | 42 | 93 |
PNH034 | 1.4 | 37 | 74 | 3.2 | 64 | 89 |
PNH042 | 0.7 | 23 | 71 | 0.7 | 36 | 85 |
PNH043 | 5.9 | 45 | 85 | 4.4 | 63 | 89 |
PNH047 | 0.1 | 33 | ND | 0.8 | 42 | ND |
PNH055 | 4.3 | 61 | 78 | 8.9 | 79 | 96 |
PNH058 | 6.1 | 51 | 90 | 7.6 | 60 | 88 |
PNH063 | 9.6 | 7 | 45 | 10.4 | 35 | 73 |
PNH072 | 15.9 | 40 | 87 | 26.0 | 86 | 99 |
PNH079 | 16.7 | 42 | 72 | 20.7 | 44 | 88 |
PNH087 | 3.7 | 43 | 95 | 2.7 | 80 | 97 |
PNH090 | 11.8 | 45 | 93 | 16.2 | 67 | 89 |
PNH091 | 17.5 | 16 | 71 | 14.6 | 24 | 53 |
Median | 10.7 | 37 | 77.5 | 12.6 | 60 | 89.5 |
Normal range3-152 | 30-52% | 54-82% |
Patient ID . | CD4+Lymphocytes3-150 . | CD8+ Lymphocytes3-150 . | ||||
---|---|---|---|---|---|---|
Size of PNH Clone % . | CD48+CD45RA+ % . | CD48−CD45RA+ % . | Size of PNH Clone % . | CD48+CD45RA+ % . | CD48−CD45RA+ % . | |
PNH007 | 24.3 | 37 | 83 | 35.8 | 89 | 99 |
PNH008 | 23.5 | 21 | 71 | 22.2 | 47 | 97 |
PNH012 | 21.3 | 40 | 89 | 32.3 | 95 | 99 |
PNH019 | 10.7 | 18 | 67 | 12.6 | 67 | 85 |
PNH020 | 16.2 | 56 | 83 | 18.2 | 44 | 98 |
PNH022 | 7.9 | 28 | 74 | 11.1 | 58 | 90 |
PNH0303-151 | 14.0 | 32 | 46 | 4.3 | 63 | 59 |
PNH033 | 21.7 | 37 | 77 | 20.7 | 42 | 93 |
PNH034 | 1.4 | 37 | 74 | 3.2 | 64 | 89 |
PNH042 | 0.7 | 23 | 71 | 0.7 | 36 | 85 |
PNH043 | 5.9 | 45 | 85 | 4.4 | 63 | 89 |
PNH047 | 0.1 | 33 | ND | 0.8 | 42 | ND |
PNH055 | 4.3 | 61 | 78 | 8.9 | 79 | 96 |
PNH058 | 6.1 | 51 | 90 | 7.6 | 60 | 88 |
PNH063 | 9.6 | 7 | 45 | 10.4 | 35 | 73 |
PNH072 | 15.9 | 40 | 87 | 26.0 | 86 | 99 |
PNH079 | 16.7 | 42 | 72 | 20.7 | 44 | 88 |
PNH087 | 3.7 | 43 | 95 | 2.7 | 80 | 97 |
PNH090 | 11.8 | 45 | 93 | 16.2 | 67 | 89 |
PNH091 | 17.5 | 16 | 71 | 14.6 | 24 | 53 |
Median | 10.7 | 37 | 77.5 | 12.6 | 60 | 89.5 |
Normal range3-152 | 30-52% | 54-82% |
As determined by three-color flow cytometry using CD48/CD45RA/CD4 and CD48/CD45RA/CD8 combinations of monoclonal antibodies as described in Materials and Methods section. Values in the table are the percentage of either CD48+ or CD48− cells expressing CD45RA.
Abbreviation: ND, too few cells for reliable assessment of CD45RA staining.
T-cell subpopulations identified on the basis of strong CD4 or CD8 positivity and low SSC characteristics.
Data from this patient excluded from statistical analysis and median value.
Normal ranges derived from a study of 12 normal adult controls.